» Articles » PMID: 18555911

Nurse-coordinated Multidisciplinary, Family-based Cardiovascular Disease Prevention Programme (EUROACTION) for Patients with Coronary Heart Disease and Asymptomatic Individuals at High Risk of Cardiovascular Disease: a Paired, Cluster-randomised...

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2008 Jun 17
PMID 18555911
Citations 155
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Our aim was to investigate whether a nurse-coordinated multidisciplinary, family-based preventive cardiology programme could improve standards of preventive care in routine clinical practice.

Methods: In a matched, cluster-randomised, controlled trial in eight European countries, six pairs of hospitals and six pairs of general practices were assigned to an intervention programme (INT) or usual care (UC) for patients with coronary heart disease or those at high risk of developing cardiovascular disease. The primary endpoints-measured at 1 year-were family-based lifestyle change; management of blood pressure, lipids, and blood glucose to target concentrations; and prescription of cardioprotective drugs. Analysis was by intention to treat. The trial is registered as ISRCTN 71715857.

Findings: 1589 and 1499 patients with coronary heart disease in hospitals and 1189 and 1128 at high risk were assigned to INT and UC, respectively. In patients with coronary heart disease who smoked in the month before the event, 136 (58%) in the INT and 154 (47%) in the UC groups did not smoke 1 year afterwards (difference in change 10.4%, 95% CI -0.3 to 21.2, p=0.06). Reduced consumption of saturated fat (196 [55%] vs 168 [40%]; 17.3%, 6.4 to 28.2, p=0.009), and increased consumption of fruit and vegetables (680 [72%] vs 349 [35%]; 37.3%, 18.1 to 56.5, p=0.004), and oily fish (156 [17%] vs 81 [8%]; 8.9%, 0.3 to 17.5, p=0.04) at 1 year were greatest in the INT group. High-risk individuals and partners showed changes only for fruit and vegetables (p=0.005). Blood-pressure target of less than 140/90 mm Hg was attained by both coronary (615 [65%] vs 547 [55%]; 10.4%, 0.6 to 20.2, p=0.04) and high-risk (586 [58%] vs 407 [41%]; 16.9%, 2.0 to 31.8, p=0.03) patients in the INT groups. Achievement of total cholesterol of less than 5 mmol/L did not differ between groups, but in high-risk patients the difference in change from baseline to 1 year was 12.7% (2.4 to 23.0, p=0.02) in favour of INT. In the hospital group, prescriptions for statins were higher in the INT group (810 [86%] vs 794 [80%]; 6.0%, -0.5 to 11.5, p=0.04). In general practices in the intervention groups, angiotensin-converting enzyme inhibitors (297 [29%] INT vs 196 [20%] UC; 8.5%, 1.8 to 15.2, p=0.02) and statins (381 [37%] INT vs 232 [22%] UC; 14.6%, 2.5 to 26.7, p=0.03) were more frequently prescribed.

Interpretation: To achieve the potential for cardiovascular prevention, we need local preventive cardiology programmes adapted to individual countries, which are accessible by all hospitals and general practices caring for coronary and high-risk patients.

Citing Articles

MetALD: Clinical aspects, pathophysiology and treatment.

Gratacos-Gines J, Arino S, Sancho-Bru P, Bataller R, Pose E JHEP Rep. 2025; 7(2):101250.

PMID: 39897615 PMC: 11782861. DOI: 10.1016/j.jhepr.2024.101250.


Smoking cessation and prognosis during long-term follow-up after stroke, TIA, and acute coronary syndrome-results from the randomized controlled NAILED trial.

Irewall A, Aslund L, Ogren J, Mooe T PLoS One. 2024; 19(11):e0311955.

PMID: 39527527 PMC: 11554128. DOI: 10.1371/journal.pone.0311955.


Lifestyle Recommendations for Patients Before and After Thoracic Aortic Surgery: A Framework Analysis.

Koenders N, van Zetten H, Smulders M, Smeenk H, van Kimmenade R, Smith T Aorta (Stamford). 2024; 12(1):1-7.

PMID: 39471987 PMC: 11606666. DOI: 10.1055/s-0044-1791668.


Challenge of cardiovascular prevention in primary care: achievement of lifestyle, blood pressure, lipids and diabetes targets for primary prevention in England - results from ASPIRE-3-PREVENT cross-sectional survey.

Kotseva K, Jennings C, Bassett P, Adamska A, Hobbs R, Wood D Open Heart. 2024; 11(2).

PMID: 39414309 PMC: 11481111. DOI: 10.1136/openhrt-2024-002704.


ProtecT-2-D trial protocol: cardiovascular protection in patients with type 2 diabetes and established heart and/or vascular disease at a cardio-metabolic clinic-a randomized controlled trial.

Overgaard K, Mohamed R, Andersen T, Lambrechtsen J, Egstrup K, Auscher S Cardiovasc Diabetol. 2024; 23(1):241.

PMID: 38978117 PMC: 11232310. DOI: 10.1186/s12933-024-02340-w.